ALEC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ALEC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Alector's EBIT per Share for the three months ended in Dec. 2023 was $-0.56. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.81.
During the past 3 years, the average EBIT per Share Growth Rate was 10.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was -5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Alector's EBIT per Share or its related term are showing as below:
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Alector was 17.80% per year. The lowest was -84.50% per year. And the median was 3.40% per year.
Alector's EBIT for the three months ended in Dec. 2023 was $-47.45 Mil.
The historical data trend for Alector's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alector Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
EBIT per Share | Get a 7-Day Free Trial | -1.85 | -2.51 | -0.47 | -1.67 | -1.81 |
Alector Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EBIT per Share | Get a 7-Day Free Trial | -0.67 | -0.60 | -0.04 | -0.60 | -0.56 |
EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.
Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.
Alector's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as
EBIT per Share | (A: Dec. 2023 ) | ||
= | EBIT | / | Shares Outstanding (Diluted Average) | = | -151.74 | / | 83.734 |
= | -1.81 |
Alector's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as
EBIT per Share | (Q: Dec. 2023 ) | ||
= | EBIT | / | Shares Outstanding (Diluted Average) | = | -47.453 | / | 84.393 |
= | -0.56 |
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alector (NAS:ALEC) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Thank you for viewing the detailed overview of Alector's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Sara Kenkare-mitra | officer: President and Head of R&D | C/O ALECTOR, INC, 131 OYSTER POINT BLVD, SUITE 600, SOUTH SAN FRANCISCO CA 94080 |
Gary Romano | officer: Chief Medical Officer | TWO COMMERCE SQUARE, 2001 MARKET STREET, 28TH FLOOR, PHILADELPHIA PA 19103 |
Arnon Rosenthal | director, officer: Chief Executive Officer | C/O ALECTOR, INC., 151 OYSTER POINT BLVD., #300, SOUTH SAN FRANCISCO CA 94080 |
Marc Grasso | officer: Chief Financial Officer | C/O KURA ONCOLOGY, INC., 3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO CA 92121 |
Terrance Mcguire | director, 10 percent owner | C/O POLARIS VENTURE PARTNERS LP, 1000 WINTER STREET, SUITE 3350, WALTHAM MA 02154 |
Polaris Venture Management Co. Vi, L.l.c. | 10 percent owner | ONE MARINA PARK DRIVE, 8TH FLOOR, BOSTON MA 02210 |
Richard H Scheller | director | C/O GENENTECH INC, 1 DNA WAY MS 49, SOUTH SAN FRANCISCO CA 94080-4990 |
Paula Hammond | director | C/O ALECTOR, INC., 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA 94080 |
Kristine Yaffe | director | C/O ALECTOR, INC., 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO CA 94080 |
Tillman U. Gerngross | director | C/O ARSANIS, INC., 890 WINTER STREET, SUITE 230, WALTHAM MA 02451 |
Lavigne Louis J Jr | director | C/O ALLERGAN, INC., 2525 DUPONT DRIVE, IRVINE CA 92612 |
Elizabeth A. Garofalo | director | C/O ACADIA PHARMACEUTICALS INC., 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO CA 92130 |
David M. Wehner | director | C/O FACEBOOK, INC., 1601 WILLOW ROAD, MENLO PARK CA 94025 |
Robert King | officer: Chief Development Officer | 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404 |
Shehnaaz Suliman | officer: President and COO | 901 GATEWAY BLVD, SOUTH SAN FRANCISCO CA 94080 |
From GuruFocus
By Marketwired • 08-03-2023
By Marketwired • 09-07-2023
By GuruFocus Research • 09-14-2023
By Value_Insider Value_Insider • 11-07-2022
By GuruFocusNews GuruFocusNews • 06-18-2022
By GuruFocusNews GuruFocusNews • 06-28-2022
By GuruFocusNews GuruFocusNews • 07-08-2022
By GuruFocusNews GuruFocusNews • 06-26-2022
By GuruFocus Research • 11-07-2023
By sperokesalga sperokesalga • 02-28-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.